Determination of Cystic Fibrosis Mutation Frequency in Preterm and Term Neonates with Respiratory Tract Problems

1 Anderson DH. Cystic fibrosis of the pancreas. J Chronic Dis. 1958; 7(1): 58–90. AndersonDH Cystic fibrosis of the pancreas J Chronic Dis 1958 7 1 58 90 10.1016/0021-9681(58)90185-1 Search in Google Scholar

2 Tuğ E, Tuğ T. Cystic fibrosis and molecular-genetic approaches. Turk Thorac J. 2003; 4(2): 198–204. TuğE TuğT Cystic fibrosis and molecular-genetic approaches Turk Thorac J 2003 4 2 198 204 Search in Google Scholar

3 De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, et al. Cystic fibrosis: Terminology and diagnostic algorithms. Thorax. 2006; 61(7): 627–635. De BoeckK WilschanskiM CastellaniC TaylorC CuppensH DodgeJ Cystic fibrosis: Terminology and diagnostic algorithms Thorax 2006 61 7 627 635 10.1136/thx.2005.043539 Search in Google Scholar

4 Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of Cystic fibrosis: Consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017; 181S: S4–S15.e1 FarrellPM WhiteTB RenCL HempsteadSE AccursoF DerichsN Diagnosis of Cystic fibrosis: Consensus guidelines from the Cystic Fibrosis Foundation J Pediatr 2017 181S S4 S15.e1 10.1016/j.jpeds.2016.09.064 Search in Google Scholar

5 Kharrazi M, Yang J, Bishop T, Lessing S, Young S, Graham S, et al. Newborn screening for cystic fibrosis in California. Pediatrics. 2015; 136(6): 1062–1072. KharraziM YangJ BishopT LessingS YoungS GrahamS Newborn screening for cystic fibrosis in California Pediatrics 2015 136 6 1062 1072 10.1542/peds.2015-0811 Search in Google Scholar

6 Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003; 168(8): 918–951. GibsonRL BurnsJL RamseyBW Pathophysiology and management of pulmonary infections in cystic fibrosis Am J Respir Crit Care Med 2003 168 8 918 951 10.1164/rccm.200304-505SO Search in Google Scholar

7 Collins FS. Cystic fibrosis: Molecular biology and therapeutic implications. Science. 1992; 256(5058): 774–779. CollinsFS Cystic fibrosis: Molecular biology and therapeutic implications Science 1992 256 5058 774 779 10.1126/science.1375392 Search in Google Scholar

8 Drumm ML, Collins FS. Molecular biology of cystic fibrosis. Mol Genet Med. 1993; 3: 33–68. DrummML CollinsFS Molecular biology of cystic fibrosis Mol Genet Med 1993 3 33 68 10.1016/B978-0-12-462003-2.50006-7 Search in Google Scholar

9 Bear CE, Li CH, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992; 68(4): 809–818. BearCE LiCH KartnerN BridgesRJ JensenTJ RamjeesinghM Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) Cell 1992 68 4 809 818 10.1016/0092-8674(92)90155-6 Search in Google Scholar

10 Guggino WB, Banks-Schlegel SP. Macromolecular interactions and ion transport in cystic fibrosis. Am J Respir Crit Care Med. 2004; 170(7): 815–820. GugginoWB Banks-SchlegelSP Macromolecular interactions and ion transport in cystic fibrosis Am J Respir Crit Care Med 2004 170 7 815 820 10.1164/rccm.200403-381WS Search in Google Scholar

11 Johnson LG, Boyles SE, Wilson J, Boucher RC. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest. 1995; 95(3): 1377–1382. JohnsonLG BoylesSE WilsonJ BoucherRC Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells J Clin Invest 1995 95 3 1377 1382 10.1172/JCI117789 Search in Google Scholar

12 Ratjen F, Döring G. Cystic fibrosis. Lancet. 2003; 361(9358): 681–689. RatjenF DöringG Cystic fibrosis Lancet 2003 361 9358 681 689 10.1016/S0140-6736(03)12567-6 Search in Google Scholar

13 Cutting GR. Cystic fibrosis genetics: From molecular understanding to clinical application. Nat Rev Genet. 2015; 16(1): 45–56. CuttingGR Cystic fibrosis genetics: From molecular understanding to clinical application Nat Rev Genet 2015 16 1 45 56 10.1038/nrg3849436443825404111 Search in Google Scholar

14 Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, Gibson RL, Marshall SG, et al. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med. 2008; 10(12): 851–868. MoskowitzSM ChmielJF SternenDL ChengE GibsonRL MarshallSG Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders Genet Med 2008 10 12 851 868 10.1097/GIM.0b013e31818e55a2281095319092437 Search in Google Scholar

15 Çolak Y, Nordestgaard BG, Afzal S. Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population. Eur Respir J. 2020; 56(3): 2000558. ÇolakY NordestgaardBG AfzalS Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population Eur Respir J 2020 56 3 2000558 10.1183/13993003.00558-202032398304 Search in Google Scholar

16 Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med. 2003; 9(6): 498–503. BoyleMP Nonclassic cystic fibrosis and CFTR-related diseases Curr Opin Pulm Med 2003 9 6 498 503 10.1097/00063198-200311000-00009 Search in Google Scholar

17 Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cystic Fibrosis. 2011; 10(Suppl 2): S86–S102. BombieriC ClaustresM De BoeckK DerichsN DodgeJ GirodonE Recommendations for the classification of diseases as CFTR-related disorders J Cystic Fibrosis 2011 10 Suppl 2 S86 S102 10.1016/S1569-1993(11)60014-3 Search in Google Scholar

18 Aznarez I, Bal J, Casals T, Estivill X, Moral N, Sands D, et al. Analysis of mutations in the CFTR gene in patients diagnosed with cystic fibrosis in Poland [Polish]. Med Wieku Rozwoj. 2000; 4(2): 149–159. AznarezI BalJ CasalsT EstivillX MoralN SandsD Analysis of mutations in the CFTR gene in patients diagnosed with cystic fibrosis in Poland [Polish] Med Wieku Rozwoj 2000 4 2 149 159 Search in Google Scholar

19 Yoshimura K, Wakazono Y, Iizuka S, Morokawa N, Tada H, Eto Y. Japanese patient homozygous for the H1085R mutation in the CFTR gene presents with a severe form of cystic fibrosis. Clin Genet. 1999; 56(2): 173–175. YoshimuraK WakazonoY IizukaS MorokawaN TadaH EtoY Japanese patient homozygous for the H1085R mutation in the CFTR gene presents with a severe form of cystic fibrosis Clin Genet 1999 56 2 173 175 10.1034/j.1399-0004.1999.560217.x Search in Google Scholar

20 Tzetis M, Kanavakis E, Antoniadi T, Traeger-Synodinos J, Doudounakis S, Adam G, et al. Identification of two novel mutations (296 + 1G-C and A46D) in exon 2 of the CFTR gene in Greek cystic fibrosis patients. Mol Cell Probes. 1995; 9(4): 283–285. TzetisM KanavakisE AntoniadiT Traeger-SynodinosJ DoudounakisS AdamG Identification of two novel mutations (296 + 1G-C and A46D) in exon 2 of the CFTR gene in Greek cystic fibrosis patients Mol Cell Probes 1995 9 4 283 285 10.1016/S0890-8508(95)90169-8 Search in Google Scholar

21 Thauvin-Robinet C, Munck A, Huet F, Génin E, Bellis G, Gautier E, et al.; Collaborating Working Group on R117H. The very low penetrance of cystic fibrosis for the R117H mutation: A reappraisal for genetic counselling and newborn screening. J Med Genet. 2009; 46(11): 752–758. Thauvin-RobinetC MunckA HuetF GéninE BellisG GautierE Collaborating Working Group on R117H The very low penetrance of cystic fibrosis for the R117H mutation: A reappraisal for genetic counselling and newborn screening J Med Genet 2009 46 11 752 758 10.1136/jmg.2009.06721519880712 Search in Google Scholar